✦ LIBER ✦

FIVE-YEAR CLINICAL OUTCOME AFTER IMPLANTATION OF SIROLIMUS-ELUTING STENTS VERSUS PACLITAXEL-ELUTING STENTS IN UNSELECTED PATIENTS WITH CORONARY ARTERY DISEASE: KOMATE DES REGISTRY

✍ Scribed by Ko, Young-Guk; Kim, Jung-Sun; Choi, Donghoon; Hong, Myeong-Ki; Jnag, Yangsoo; Min, Pil Ki; Yoon, Young Won; Hong, Bum-Kee; Lee, Byoung Kwon; Kwon, Hyuck Moon

Book ID: 122919587
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 126 KB
Volume: 55
Category: Article
ISSN: 1558-3597
DOI: 10.1016/S0735-1097(10)61805-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Three-year outcomes following sirolimus-

Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease: The REWARDS Registry

✍ Nicholas Hanna; Michael A. Gaglia Jr; Rebecca Torguson; Itsik Ben-Dor; Sara D. C 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Three-Year Outcomes Following Sirolimus-

Three-Year Outcomes Following Sirolimus- Versus Paclitaxel-Eluting Stent Implantation in an Unselected Population With Coronary Artery Disease (from the REWARDS Registry)

✍ Nicholas N. Hanna; Michael A. Gaglia Jr.; Rebecca Torguson; Itsik Ben-Dor; Manue 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 397 KB

Five-year clinical outcomes of sirolimus

Five-year clinical outcomes of sirolimus-eluting versus paclitaxel-eluting stents in high-risk patients

✍ K. Anette Birkmeier; Adnan Kastrati; Robert A. Byrne; Heidrun Holle; Stefanie Sc 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB 👁 2 views

## Abstract Objectives and Background: First generation drug‐eluting stents have shown differential efficacy in high‐risk patient subsets at one year. It is unclear whether these differences endure over the medium‐ to long‐term. We compared the five‐year clinical efficacy and safety of sirolimus‐el

Long-Term Clinical Outcomes and Thrombos

Long-Term Clinical Outcomes and Thrombosis Rates of Sirolimus-Eluting Versus Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease (REWARDS Registry)

✍ Ron Waksman; Ashesh N. Buch; Rebecca Torguson; Zhenyi Xue; Kimberly Smith; Aamir 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Two-Year Outcome of Patients Treated Wit

Two-Year Outcome of Patients Treated With Sirolimus- Versus Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease (from the REWARDS Registry)

✍ Probal Roy; Laurent Bonello; Axel de Labriolle; Teruo Okabe; Tina L. Pinto Slott 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 409 KB

Sirolimus-Eluting Stents Versus Paclitax

Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in the Treatment of Coronary Artery Disease in Patients With Diabetes Mellitus

✍ Pramod K. Kuchulakanti; William W. Chu; Rebecca Torguson; Leonardo Clavijo; Rosw 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 158 KB